ZTS
Zoetis Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$84.22
−5.59%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.51
- Revenue estimate
- $2.3B
Latest reported
- Last report date
- Nov 5, 2026
- EPS actual
- $1.87
- EPS estimate
- $1.85
- Revenue actual
- $2.5B
- Revenue estimate
- $2.5B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.2%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $90
- PT range
- $74 – $115
- Analysts
- 11
5 Buy6 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 5, 2026 | $1.51 | $1.75 | Beat 15.89% | $2.4B |
| Aug 6, 2026 | $1.85 | $1.87 | Beat 1.08% | $2.5B |
| May 7, 2026 | $1.60 | $1.53 | Miss -4.38% | $2.3B |
| Feb 12, 2026 | $1.40 | $1.48 | Beat 5.71% | $2.4B |
| Feb 13, 2025 | $1.37 | $1.40 | Beat 2.19% | $2.3B |
| May 2, 2024 | $1.34 | $1.38 | Beat 2.99% | $2.2B |
| Feb 13, 2024 | $1.32 | $1.24 | Miss -6.06% | $2.2B |
| Nov 2, 2023 | $1.36 | $1.36 | In line | $2.2B |
| May 4, 2023 | $1.26 | $1.31 | Beat 3.80% | $2.0B |
| Feb 14, 2023 | $1.05 | $1.15 | Beat 9.52% | $2.0B |
| Nov 3, 2022 | $1.24 | $1.21 | Miss -2.58% | $2.0B |
| Aug 4, 2022 | $1.22 | $1.20 | Miss -1.88% | $2.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026